08:00 CET

Year-end Report 2020

Oncopeptides will also hold a webcast Thursday February 18, 2021 at 14:00 (CET) when the Year-end Report 2020 and an operational update will be presented by CEO Marty J Duvall, CMO Klaas Bakker and CFO Anders Martin-Löf.

The conference call will also be streamed via the link: https://tv.streamfabriken.com/oncopeptides-q4-2020

Phone numbers for participants from:
Sweden: +46 8 566 426 95
Europe: +44 3333 009 030
USA: +1 833 526 83 47

 

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-